EQT Life Sciences Boosts Noema Pharma's Series B Funding to CHF 130 Million EQT Life Sciences leads a Series B funding extension for Noema Pharma, increasing investment total to CHF 130 million, targeting CNS disorders.

EQT Life Sciences Boosts Noema Pharma's Series B Funding to CHF 130 Million #Switzerland #EQT_Life_Sciences #Noema_Pharma #CNS_disorders #Basel